Abstract

Previous studies have shown that (i) the insulin-induced activation of heart 6-phosphofructo-2-kinase (PFK-2) is wortmannin-sensitive, but is insensitive to rapamycin, suggesting the involvement of phosphatidylinositol 3-kinase; and (ii) protein kinase B (PKB) activates PFK-2 in vitro by phosphorylating Ser-466 and Ser-483. In this work, we have studied the effects of phosphorylation of these residues on PFK-2 activity by replacing each or both residues with glutamate. Mutation of Ser-466 increased the V(max) of PFK-2, whereas mutation of Ser-483 decreased citrate inhibition. Mutation of both residues was required to decrease the K(m) for fructose 6-phosphate. We also studied the insulin-induced activation of heart PFK-2 in transfection experiments performed in human embryonic kidney 293 cells. Insulin activated transfected PFK-2 by phosphorylating Ser-466 and Ser-483. Kinase-dead (KD) PKB and KD 3-phosphoinositide-dependent kinase-1 (PDK-1) cotransfectants acted as dominant negatives because both prevented the insulin-induced activation of PKB as well as the inactivation of glycogen-synthase kinase-3, an established substrate of PKB. However, the insulin-induced activation of PFK-2 was prevented only by KD PDK-1, but not by KD PKB. These results indicate that the insulin-induced activation of heart PFK-2 is mediated by a PDK-1-activated protein kinase other than PKB.

Highlights

  • The stimulation of heart glycolysis by insulin results from the stimulation of glucose transport and the activation of 6-phosphofructo-2-kinase (PFK-2),1 the enzyme that synthe

  • The insulin-induced activation of PFK-2 was prevented only by KD phosphoinositide-dependent kinase-1 (PDK-1), but not by KD protein kinase B (PKB). These results indicate that the insulin-induced activation of heart PFK-2 is mediated by a PDK-1-activated protein kinase other than PKB

  • To test the hypothesis that PKB is required for the insulin-induced activation of heart PFK-2, we carried out transfection experiments in human embryonic kidney (HEK)-293 cells, which contain the components of the insulin signaling pathways and have been used in mechanistic studies (9 –11)

Read more

Summary

Introduction

The stimulation of heart glycolysis by insulin results from the stimulation of glucose transport and the activation of 6-phosphofructo-2-kinase (PFK-2), the enzyme that synthe-. To test the hypothesis that PKB is required for the insulin-induced activation of heart PFK-2, we carried out transfection experiments in human embryonic kidney (HEK)-293 cells, which contain the components of the insulin signaling pathways and have been used in mechanistic studies (9 –11). HEK-293 cells were transfected with cDNA constructs coding for recombinant wild-type protein kinase B; PDK-1, 3-phosphoinositide-dependent kinase-1; GSK-3, glycogen synthase kinase-3; HEK, human embryonic kidney; BH1(His), polyhistidine-tagged recombinant bovine heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase; EE-GSK-3, EFMPME epitope-tagged GSK-3; HA-PKB, hemagglutinin-tagged PKB; KD, kinase-dead; GST, glutathione S-transferase; Mops, 4-morpholinepropanesulfonic acid; MALDI-MS, matrix-assisted laser desorptionionization mass spectrometry; HPLC, high performance liquid chromatography. Heart 6-Phosphofructo-2-kinase Activation by Insulin bovine heart PFK-2 (BH1) and mutants In these cells, we studied the effect of insulin on the extent of phosphorylation and changes in PFK-2 activity, and we identified the phosphorylation sites in the wild-type and the three mutants. Our findings suggest the possible participation of PDK-1-activated protein kinase(s), other than PKB, in the insulin signaling pathway that activates PFK-2

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call